Table 2 |
|||
|
Primary and secondary outcome at 3 months |
|||
|
Variables |
Intervention group (n = 14) |
Control group (n = 22) |
Between-group difference (p valuea) |
|
|
|||
|
Primary outcome |
|||
|
ACR (mg/gCr) |
|||
|
Baseline |
706.1 ± 1081.2 |
212.5 ± 322.5 |
|
|
After 3 months |
440.0 ± 656.3 |
163.5 ± 161.5 |
|
|
Change |
-266.1 ± 436.3 |
-49.0 ± 261.2 |
0.070 |
|
Within-group difference (p valueb) |
0.040 |
0.388 |
|
|
|
|||
|
Secondary outcome |
|||
|
Systolic blood pressure (mmHg) |
|||
|
Baseline |
145.1 ± 13.9 |
134.9 ± 13.1 |
|
|
After 3 months |
130.9 ± 12.9 |
130.9 ± 14.0 |
|
|
Change |
-14.3 ± 13.9 |
-4.0 ± 14.6 |
0.043 |
|
Within-group difference (p valueb) |
0.002 |
0.212 |
|
|
Diastolic blood pressure (mmHg) |
|||
|
Baseline |
67.1 ± 8.3 |
66.4 ± 12.2 |
|
|
After 3 months |
62.7 ± 7.6 |
66.8 ± 7.8 |
|
|
Change |
-4.4 ± 7.6 |
0.5 ± 11.3 |
0.165 |
|
Within-group difference (p valueb) |
0.048 |
0.853 |
|
|
|
|||
|
Abbreviation: ACR, urine albumin-creatinine ratio Data are mean ± SD. aTwo-way ANOVA bPaired t-test |
|||
|
Fujiwara et al. Asia Pacific Family Medicine 2010 9:6 doi:10.1186/1447-056X-9-6 |
|||
